Due to the concerns over the spread of COVID-19, the CEPI / IABS / ZAPI workshop
has been rescheduled
Objectives of the meeting
IABS is a non-for-profit organisation working for many years on dialogue between regulators, academia and industry on scientific topics. Its European affiliate IABS-EU is a partner in the IMI project ZAPI where the discussion is on the table on how the development of platform technologies for vaccines can improve preparedness for emerging diseases.
The idea of the symposium is to discuss with the regulators the potential benefit of creating a specific registration procedure for Vaccine platform technology.
CEPI (Coalition for Epidemic Preparedness Innovations) is non-for-profit organisation that is working in the field of development of neglected and emerging diseases and would like to help the discussion to shorten the development time for vaccines against these diseases with particular emphasis on platform technologies. Several vaccine projects sponsored by CEPI face obvious difficulties in the conduct of clinical trials. However, pushing vaccine development as far as possible to be ready timely in outbreak situations also supposes consideration and support from authorities, keeping safety of the at exposed population as a priority